Oral cannabis produced higher urine drug test concentrations than vaporized cannabis | Research

The takeaway

In a controlled study of 21 infrequent cannabis users, oral cannabis triggered positive urine tests 97.6% of the time versus 59.5% for vaporized cannabis at standard workplace cutoffs.

People subject to workplace drug testing, employers setting testing policies, and forensic toxicologists.

97.6% positive (oral) vs 59.5% positive (vaporized) at standard cutoffs

What the researchers found

Using federal workplace drug-testing criteria (50 ng/mL screening, 15 ng/mL confirmation), urine specimens tested positive for THC-COOH in 97.6% of oral cannabis sessions versus 59.5% of vaporized sessions at active THC doses.

Why it matters

With vaping and edibles now common methods of cannabis consumption, understanding how different administration routes affect drug testing has direct implications for workplace testing policies and legal proceedings.

The numbers in context

21 participants. Peak concentrations occurred at 5-6 hours (oral) and 4 hours (vaporized). At active doses, 97.6% of oral sessions and 59.5% of vaporized sessions produced positive results at standard federal cutoffs. Oral administration produced quantitatively higher maximum concentrations for all detected analytes.

How the study worked

Double-blind, six-session study of 21 infrequent cannabis users (11 men, 10 women). Participants ingested cannabis brownies (0, 10, 25 mg THC) and inhaled vaporized cannabis (0, 5, 20 mg THC). Urinary concentrations of 9 cannabinoid analytes measured at baseline and for 8 hours.

What this study cannot tell us

Only 21 participants, all infrequent users. The 8-hour window may not capture the full excretion profile. Results may not generalize to frequent users who have accumulated THC stores.

How to read the evidence

Moderate: controlled, double-blind design with biological measures, but small sample of infrequent users only.

When this study was published

Published in 2022.

The bigger picture

Drug testing protocols were designed around smoked cannabis. As consumption methods diversify, the detection characteristics of each method need to be understood to ensure testing policies remain fair and accurate.

Questions still open

Should workplace drug testing cutoffs be adjusted to account for consumption method? Could 11-OH-THC serve as a better confirmatory analyte for distinguishing legal from illicit cannabis products? How do these profiles differ in frequent users?

Common questions

Why does oral cannabis produce higher urine concentrations?

When cannabis is eaten, it undergoes extensive first-pass metabolism in the liver, producing higher concentrations of detectable metabolites compared to inhaled cannabis, which enters the bloodstream more directly through the lungs.

Could vaping cannabis help avoid a positive drug test?

Not reliably. While vaporized cannabis produced fewer positives (59.5%) than oral (97.6%), the majority of vaporized sessions still triggered positive results at standard cutoffs.

What are the standard federal drug testing cutoffs?

The recommended federal workplace criteria use a 50 ng/mL immunoassay screening cutoff followed by a 15 ng/mL confirmation cutoff via LC-MS/MS for THC-COOH.

Read the original research

Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.

Journal of analytical toxicology, 46(8), 882-890

View on PubMed ↗Publisher’s paper ↗

Citation

Sholler, Dennis J; Zamarripa, C Austin; Spindle, Tory R; Martin, Erin L; Kuntz, David; Vandrey, Ryan; Grabenauer, Megan. (2022). Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.. Journal of analytical toxicology, 46(8), 882-890. https://doi.org/10.1093/jat/bkac042